Top Markets
Coin of the day
Foresee Pharmaceuticals Co., Ltd. Foresee Pharmaceuticals Co., Ltd.

Foresee Pharmaceuticals Co., Ltd.

6576
Rank in Stocks #14583
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key... Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
Share Price
$2.58
Market Cap
$405.78M
Change (1 day)
-0.25%
Change (1 year)
1.54%
Country
TW
Trade Foresee Pharmaceuticals Co., Ltd. (6576)

Category

P/S ratio for Foresee Pharmaceuticals Co., Ltd. (6576)
P/S ratio as of 2026 TTM: 0
According to Foresee Pharmaceuticals Co., Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Foresee Pharmaceuticals Co., Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors